In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 26 for your search:
Drug:  acetylsalicylic acid
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care
Status: Enrolling by invitation
Age: 18 to 80
Sponsor: Other
Protocol IDs: PZ-1001-403-NS, NCT01621451

2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 30 and over
Sponsor:
Protocol IDs: PVSG-10

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-875001, MAYO-875001, NCCTG-87-50-01

4.

Phase: Phase III
Type: Prevention
Status: Completed
Age: over 30 to under 75
Sponsor: NCI, Other
Protocol IDs: CDR0000078380, CLB-9270, E-C9270, NCCTG-949251, NCI-P93-0048, NCT00002527

5.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: BARTS-DAVDAS, EU-20610, ISRCTN13255144, NCT00316927

6.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Health services research, Prevention
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000491649, OCTO-003, EUDRACT-2004-003836-77, ISRCTN85156844, EU-20628, OCTO-ASPECT, RADCLIFFE-32, ZENECA-RADCLIFFE-32, NCT00357682

7.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03150, CDR0000404161, E4A03, U10CA021115, U10CA180820, ECOG-E4A03, NCT00098475

8.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 45 and over
Sponsor: NCI, Other
Protocol IDs: 69, R01HL043851, HL043851, CA047988, NCT00000479

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BRMP-8802D, NCI-88-C-84D, NCI-T88-0103N, T88-0103

10.

Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000068028, NCI-00-C-0128, MB-401, NCI-T99-0066, T99-0066, NCT00020189

11.

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: MAYO-851901, NCI-T85-0264D, T85-0264

12.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: RPMI-DS-8816, NCI-V88-0553

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 05-0427 / 201107340, NCT00263211

14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00838, MAY04-4-01, CDR0000544180, MAYO-MAY04-4-01, N01CN35000, NCT00474903

15.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: RV-PI-0103, 07/04, NCT00482261

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: Under 75
Sponsor: NCI
Protocol IDs: NCI-2009-00841, CDR0000652929, NCI 04-2-03, NWU04-2-03, N01CN35157, NU-NWU04-2-03, NCT00468910

17.

Phase: Phase I
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CCUM-9215, NCI-P93-0040

18.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Unknown
Age: Not specified
Sponsor: Other
Protocol IDs: INHANSE-ASPOD, ASPOD, EU-21083, ASPOD, ISRCTN-31503555, EU-21083, NCT01238185

19.

Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7803

20.

Phase: No phase specified
Type: Prevention
Status: Closed
Age: 21 to 80
Sponsor: NCI
Protocol IDs: DMS-CPHS-10293, NCI-P95-0063

21.

Phase: No phase specified
Type: Treatment
Status: Closed
Age: 21 and over
Sponsor:
Protocol IDs: PVSG-5

22.

Phase: No phase specified
Type: Prevention
Status: Closed
Age: 75 and under
Sponsor: Other
Protocol IDs: QMC-UKCAP, EU-20045, NCT00033319

23.

Phase: No phase specified
Type: Prevention
Status: Closed
Age: 45 to 74
Sponsor: Other
Protocol IDs: 01426-V, 05-7956-V 01, 28526-V, NCT00234299

24.

Phase: No phase specified
Type: Treatment
Status: Closed
Age: 18 to 95
Sponsor: Other
Protocol IDs: V0801, NCT00727948

25.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 55 to 75
Sponsor: NCI, Other
Protocol IDs: PHS 1908.00, FHCRC-PHS-1908.00, FHCRC-1908, CDR0000544639, NCT00470561
1   
New Search